BARCLAYS PLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 1 filers reported holding ITEOS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,529
-15.4%
322,322
+2.4%
0.00%
-33.3%
Q2 2023$4,169
+19.2%
314,880
+22.5%
0.00%
+50.0%
Q1 2023$3,497
-29.8%
256,956
+0.8%
0.00%0.0%
Q4 2022$4,980
-99.9%
254,961
+14.9%
0.00%
-60.0%
Q3 2022$4,226,000
+592.8%
221,843
+648.9%
0.01%
Q2 2022$610,000
-77.4%
29,623
-64.7%
0.00%
-100.0%
Q1 2022$2,703,00083,9990.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 3,706,663$126,694,00024.48%
MPM BioImpact LLC 2,355,557$80,513,00010.12%
Boxer Capital, LLC 4,345,016$148,513,0005.04%
RA Capital Management 4,417,258$150,982,0002.28%
Ally Bridge Group (NY) LLC 322,794$11,033,0002.12%
Asymmetry Capital Management, L.P. 102,286$3,496,0001.81%
RTW INVESTMENTS, LP 2,762,791$94,432,0001.47%
COWEN AND COMPANY, LLC 588,238$20,106,0001.38%
Artal Group S.A. 1,094,047$37,395,0000.66%
HighVista Strategies LLC 19,804$677,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders